Identification of a Therapeutic Dose of Continuously Delivered Erythropoietin in the Eye Using An Inducible Promoter System

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|13|4|275-281

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.13, Iss.4, 2013-08, pp. : 275-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardioprotection by Recombinant Human Erythropoietin Following Acute Experimental Myocardial Infarction: Dose Response and Therapeutic Window

By Moon Chanil   Krawczyk Melissa   Paik Doojin   Lakatta Edward   Talan Mark  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 4, 2005-08 ,pp. : 243-250

Springer Publishing Company

Access to resources Recommend Favorite

Study of Eye Drops Dispensing and Dose Variability by Using Plastic Dropper Tips

By Šklubalová Zdenka   Zatloukal Zdenek  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 2, 2006-03 ,pp. : 197-205

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Strategy of Erythropoietin in Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

The Chemokine System as a Therapeutic Target in Autoimmune Thyroid Diseases: A Focus on the Interferon-&ggr; Inducible Chemokines and their Receptor

By  

Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. : 3202-3216

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphisms in Assessing Interindividual Variability in Delivered Dose

By Haber L.T.   Maier A.   Gentry P.R.   Clewell H.J.   Dourson M.L.  

Regulatory Toxicology and Pharmacology, Vol. 35, Iss. 2, 2002-04 ,pp. : 177-197

Academic Press

Access to resources Recommend Favorite